Histone deacetylase 2

Histone Deacetylase 2

File:HDAC2 attacking lysine residue.pdf

HDAC2 attacking lysine residue

Histone deacetylase 2 (HDAC2) is an enzyme that plays a critical role in the regulation of gene expression by modifying chromatin structure. It is a member of the histone deacetylase family, which is involved in the removal of acetyl groups from lysine residues on histone proteins. This deacetylation process leads to chromatin condensation and transcriptional repression.

Structure and Function

HDAC2 is part of the class I HDACs, which are homologous to the yeast Rpd3 protein. It is ubiquitously expressed in various tissues and is involved in numerous cellular processes, including cell cycle progression, differentiation, and apoptosis.

The enzyme functions as part of a larger multiprotein complex, often associating with co-repressor proteins such as Sin3A, N-CoR, and SMRT. These complexes are recruited to specific genomic loci by transcription factors, where they exert their repressive effects on gene expression.

Mechanism of Action

HDAC2 catalyzes the removal of acetyl groups from the ε-amino groups of lysine residues on histone tails. This action is crucial for the regulation of chromatin structure and function. The deacetylation of histones by HDAC2 results in a more compact chromatin structure, thereby reducing the accessibility of the DNA to transcriptional machinery and leading to transcriptional repression.

File:HDAC2 Chem 183.pdf

HDAC2 chemical structure

Biological Significance

HDAC2 is involved in the regulation of a wide array of genes and is essential for normal cellular function. It plays a significant role in the development and function of the nervous system, and its dysregulation has been implicated in various neurological disorders, including Alzheimer's disease and Huntington's disease.

In addition to its role in the nervous system, HDAC2 is also involved in the regulation of immune responses and has been linked to inflammatory diseases. Its activity is tightly regulated by post-translational modifications and interactions with other proteins.

Clinical Implications

Given its role in gene regulation, HDAC2 is a target for therapeutic intervention in various diseases. HDAC inhibitors, which block the activity of HDACs, are being explored as potential treatments for cancer, neurodegenerative diseases, and other conditions. These inhibitors can reactivate silenced genes and induce cell cycle arrest, differentiation, or apoptosis in cancer cells.

Related Pages

• Histone deacetylase
• Chromatin
• Gene expression
• Transcriptional repression
• Epigenetics